Genetic liability to substance use disorders can be parsed into loci that confer general or
substance-specific addiction risk. We report a multivariate genome-wide association meta-…

Genetic mechanisms of alternative mRNA splicing have been shown in the brain for a
variety of neuropsychiatric traits, but not substance use disorders. Our study utilized RNA-…

We integrated genomic and bioinformatic analyses, using data from the largest genome-wide
association study of cocaine dependence (CD; n = 6546; 82.37% with CD; 57.39% male) …

We investigated the genetic and molecular architecture of cocaine dependence (CD) and
cocaine use by integrating genome‐/transcriptome‐wide analyses. To prioritize candidates for …

Opiate/opioid use disorder (OUD) is a chronic relapsing brain disorder that has increased in
prevalence in the last two decades in the United States. Understanding the molecular …

… Spencer B Huggett was involved in data acquisition, cleaning the data, performing
statistical analyses and writing the initial draft of the manuscript. Matt McGue was involved in …

… Spencer B. Huggett wrote the initial draft of the research article, performed all data analyses
and contributed to the overall study design. Evan Winiger aided with the literature search of …

We investigated the etiological role of genetic and environmental influences for two milestones
of tobacco and alcohol use: age of initiation, and speed of progression to dependence (…

Background Rodent paradigms and human genome‐wide association studies (GWAS) on
drug use have the potential to provide biological insight into the pathophysiology of addiction. …

Cocaine use presents a worldwide public health problem with high socioeconomic cost. No
current pharmacologic treatments are available for cocaine use disorder (CUD) or cocaine …